Sign In
Buy IQV
$182.05
+1.41 (+0.781%)
At Close: Jun 03, 2026
Interpreting IQVIA (IQV) International Revenue Trends
10:22am, Monday, 04'th Nov 2024
Evaluate IQVIA's (IQV) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
IQVIA (IQV) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
09:31pm, Thursday, 31'st Oct 2024
While the top- and bottom-line numbers for IQVIA (IQV) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare
IQVIA Holdings Inc. (IQV) Q3 2024 Earnings Call Transcript
03:52pm, Thursday, 31'st Oct 2024
IQVIA Holdings Inc. (NYSE:IQV ) Q3 2024 Results Conference Call October 31, 2024 9:00 AM ET Company Participants Kerri Joseph - Senior Vice President, Investor Relations & Treasury Ari Bousbib - Chair
IQVIA Earnings & Revenues Surpass Estimates in Q3, Increase Y/Y
02:15pm, Thursday, 31'st Oct 2024
Strength in the Research and Development, and Technology and Analytics segments drives IQV's top line in the third quarter of 2024.
IQVIA lowers annual revenue forecast amid trial delays
12:50pm, Thursday, 31'st Oct 2024
Contract research firm IQVIA lowered its annual revenue forecast on Thursday, due to delays in two clinical trials as one of its clients faces logistical challenges.
IQVIA Holdings (IQV) Q3 Earnings and Revenues Beat Estimates
09:16am, Thursday, 31'st Oct 2024
IQVIA Holdings (IQV) came out with quarterly earnings of $2.84 per share, beating the Zacks Consensus Estimate of $2.81 per share. This compares to earnings of $2.49 per share a year ago.
IQVIA Reports Third-Quarter 2024 Results and Announces Investor Day
07:00am, Thursday, 31'st Oct 2024
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to
IQVIA Gears Up to Report Q3 Earnings: Here's What You Should Know
12:51pm, Monday, 28'th Oct 2024
IQV's TAS and RD&S revenues are anticipated to have increased, while CSMS revenues are likely to have dipped in the third quarter of 2024.
Seeking Clues to IQVIA (IQV) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics
10:20am, Monday, 28'th Oct 2024
Besides Wall Street's top -and-bottom-line estimates for IQVIA (IQV), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quart
IQVIA Holdings (IQV) Reports Next Week: Wall Street Expects Earnings Growth
11:06am, Thursday, 24'th Oct 2024
IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IQVIA to Announce Third-Quarter 2024 Results on October 31, 2024
04:15pm, Tuesday, 15'th Oct 2024
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its third-quarter 2024 financial results before the market opens on Thursday, October 31, 2024
Here's Why You Should Retain IQVIA Holdings Shares Now
12:51pm, Friday, 04'th Oct 2024
While IQV benefits from its market leadership, data-driven innovation and global expansion, it must navigate pricing pressure.
Here's Why IQVIA Holdings (IQV) is a Strong Value Stock
10:47am, Friday, 04'th Oct 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
IQVIA AI Solution Receives 2024 Frost & Sullivan Global Customer Value Leadership Award
09:00am, Thursday, 19'th Sep 2024
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry,
IQV Gains From Clinical Development Capabilities Amid Low Liquidity
12:35pm, Tuesday, 17'th Sep 2024
IQVIA's vast database, health-care-specific IT infrastructure and analytics-driven developments enable it to grow in the $300-billion market.
